Inactive Instrument
CUSPIS CAP L Share Price Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 246M 173M 150M 140M 128M 243M 16.51B 1.65B 647M 8.22B 649M 635M 27.56B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 246M 173M 150M 140M 128M 243M 16.51B 1.65B 647M 8.22B 649M 635M 27.56B | EV / Sales 2026 * |
88x | EV / Sales 2027 * | 3.37x |
| Free-Float |
86.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 09/08/2016 |
Joshua George
DFI | Director of Finance/CFO | - | 07/04/2024 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 21/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 09/08/2016 |
Robert Galyen
BRD | Director/Board Member | - | 30/06/2023 |
Jack Perkowski
CHM | Chairman | 76 | 23/10/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 177M | ||
| +2.99% | -0.77% | +77.83% | +12.51% | 4.99B | ||
| +10.07% | +29.44% | -13.52% | -31.68% | 2.73B | ||
| +5.38% | +2.58% | -14.99% | +65.50% | 707M | ||
| +0.14% | +9.40% | -7.79% | -47.99% | 618M | ||
| +5.29% | +4.29% | +27.54% | +6.46% | 568M | ||
| +1.73% | +5.87% | -23.41% | -16.68% | 275M | ||
| +0.73% | +27.84% | -32.56% | -18.49% | 275M | ||
| +4.61% | +7.43% | -47.52% | -49.52% | 197M | ||
| Average | +5.01% | +8.62% | -4.30% | -9.99% | 1.29B | |
| Weighted average by Cap. | +5.07% | +6.61% | +31.56% | -2.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.97M 1.71M 1.59M 1.46M 2.76M 188M 18.75M 7.36M 93.41M 7.38M 7.22M 313M | 73M 51.24M 44.55M 41.46M 38.07M 71.89M 4.89B 489M 192M 2.44B 192M 188M 8.17B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















